Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback

Not Applicable

Completed

• Conditions: Lung Cancer
• Interventions: Device: Breathe Well

• Registration Number: NCT04323618
• Lead Sponsor: University of Sydney

Brief Summary

Investigation of respiratory-related tumour motion in liver cancer patients undergoing stereotactic body radiotherapy treatment (SBRT) using audiovisual (AV) biofeedback.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-04
• Primary Completion: 2018-04
• Study Completion: 2018-04
• Study First Submitted: 2018-05-03
• Status Verified: 2020-03
• Study First Submitted QC: 2020-03-24
• Last Update Submitted: 2020-03-24
• Study First Posted: 2020-03-26
• Last Update Posted: 2020-03-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Liver cancer patients, either primary hepatocellular carcinoma or liver metastases, eligible for stereotactic radiotherapy.
• >18 years old
• Radio-opaque markers implanted (fiducials and/or surgical clips previously implanted in the liver)
• Able to give written informed consent and willingness to participate and comply with the study

Read More

Exclusion Criteria

• Pregnant / lactating women

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Free breathing or Breathe Well	Breathe Well	Free breathing or Breathe Well

Primary Outcome Measures

Name	Time	Method
Improvement in reproducibility of respiratory-related tumour motion (via fiducial maker surrogacy) for liver cancer patients treated with the AV biofeedback respiratory guidance system.	2 years